Pushed out of school by pregnancy at 13, Amina is now a 17-year-old secondary student in Uganda’s West Nile region thanks to cash support and mentoring from an EU-funded program, and she plans to become a nurse.
Volunteers in Masaka, Uganda, have received the first doses of ChAdOx1 BDBV, an Oxford-developed vaccine against Bundibugyo virus disease, a severe form of Ebola that has no licensed vaccine. The phase I trial will test safety and immune response.
